Shenzhen Keyto Fluid Control Co., Ltd, a China-based manufacturer of precision fluid control components, has reportedly raised over RMB 100 million (USD 14.86 million) in a Series C financing round. The funding was led by Kinghall Ventures, with contributions from Hawkins Capital and Plow Capital. The proceeds will be used to advance new product development, acquire special precision production instruments, high-precision detection equipment, and establish an efficient human-machine integrated automatic production line. Additionally, the funds will support the expansion of Keyto Fluid’s global market channels.
Company Overview and Achievements
Founded in 2010, Keyto Fluid Control has established itself as a leader in the field of precision fluid control components. The company operates three subsidiaries in Shenzhen and Chengdu and has undertaken multiple national and municipal medical device key component research projects. These projects include the development of a ventilator proportional valve and a gene sequencer bonding manifold, highlighting Keyto Fluid’s commitment to innovation and quality in medical device manufacturing.
Future Outlook
The Series C financing round marks a significant milestone for Keyto Fluid Control, positioning the company to accelerate its growth and expand its global footprint. With the investment, Keyto Fluid aims to enhance its production capabilities, develop cutting-edge products, and strengthen its market presence. The company’s dedication to precision and innovation underscores its potential to become a key player in the global medical device component market.-Fineline Info & Tech
